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Abbreviations
EBNA Epstein–Barr nuclear antigen
EBV Epstein–Barr virus
HE Hematoxylin eosin
HHV-8 Human herpes virus 8
HIV Human immunodeficiency virus
IVIG Intravenous immunoglobulin
KS Kaposi Sarcoma
MFI Mean fluorescence intensity
PBMC Peripheral blood mononuclear cells
PID Primary immunodeficiency
PLCγ1 Phospholipase C gamma 1
TCR T cell receptor
WES Whole exome sequencing
WGS Whole genome sequencing
X-
MEN
X-linked immunodeficiency with magnesium de-
fect, Epstein–Barr virus infection, and neoplasia
To the Editor
Kaposi sarcoma (KS) in children is rare and generally associ-
ated with loss of CD4+ T cells in human immunodeficiency
virus (HIV) infected patients and impaired immunity to hu-
man herpes virus 8 (HHV-8), or is caused by specific single-
gene inborn errors in IFNGR1,WAS, STIM1, andOX40 genes,
that apparently confer selective protective immunity against
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HHV-8 infection in endothelial cells. Four clinical and epide-
miological forms of KS have been defined: the endemic (typ-
ical of the Sub-Saharan African), the classical (observed in the
Mediterranean Basin), the epidemic (mainly associated with
HIV co-infection), and the iatrogenic (due to transplantation-
related immunosuppression). Although a small fraction of af-
fected individuals can develop KS after infection with HHV-8,
very few reports described a direct relationship between im-
munodeficiency and clinical spectrum of KS [1–3]. Classical
KS is rare in children, although several reports associated its
development with inborn errors of immunodeficiency.
The hallmark of X-linked immunodeficiency with magne-
sium defect, Epstein–Barr virus infection (EBV), and neopla-
sia (X-MEN) disease is uncontrolled EBV infection, causing a
strong susceptibility to B cell lymphoma, even in childhood
[4]. To date, 10 male X-MEN patients have been described [5]
with CD4-lymphopenia and susceptibility to EBV infection
([4], S1), but none had shown KS manifestations. Herein,
we describe for the first time a possible relationship between
KS and a magnesium-specific transporter defect caused by a
large deletion in theMAGT1 gene identified by whole exome
(WES) and confirmed by whole genome (WGS) sequencing
in a young Italian male patient.
Our patient is an Italian male from the Mediterranean Basin
referred to the Ospedale Pediatrico Bambino Gesù at the age of
3 years for cognitive and language delay and a history of recur-
rent infections. During infancy, recurrent upper respiratory
infections and lymphadenopathies were observed and resolved
with antibiotic therapy. Respiratory failure caused a subsequent
hospitalization at the age of 4 years. At 5 years of age, he
developed a cervical lymph node enlargement initially
interpreted as a mesenchymal malignancy suggestive of
monophasic synovial sarcoma, treated according to the national
RMS96 protocol for soft-tissue sarcomas (including ifos-
famide, vincristine, and actinomycin D). Review of the original
pathology before chemotherapy performed because of unres-
ponsive disease included HE staining (Fig. 1 slice A) and im-
munohistochemistry for HHV-8 (Fig. 1 slice B) and CD34
(Fig. 1 slice C). Both markers stained positively in spindle cells,
thus supporting the histological diagnosis of KS. Unless the
clinical presentation is consistent with the endemic form of
KS, the patient was negative for HIV antigen and, given his
geographic location, was considered as affected by the classic
form of KS as previously reported in other known inherited
immunodeficiencies [1–3]. Chemotherapy was discontinued,
and the patient subsequently received weekly subcutaneous
peginterferon alfa-2b (PegIntron) and IVIG every 21 days.
This led to a complete remission of disease. Gallbladder stones
were detected at 6 years of age. Because of recurrent respiratory
infections, bronchiectasis and hypogammaglobulinemia, the
patient was referred to our ImmunologyUnit. Informed consent
was obtained from the patient included in the study and was
approved by the Institutional Ethical Committee of Ospedale
Pediatrico Bambino Gesù and signed by his family.
Immunological investigations confirmed defects in various
components of adaptive and innate immunity (Table S1).
Mild reduced frequency of T cell subsets was observed, with
severely decreased naïve CD4 and CD8 T cell counts. B cell
compartment progressively expanded, but a marked reduction
of memory B cells and almost absent memory and switched
memory B cells were noted. Further functional characterization
of B cells revealed proliferation after CpG stimulation, but no
differentiation to Ig secreting B cells was observed, with unde-
tectable levels of IgG and only small amounts of IgM and IgA
in the supernatants. Chronically elevated EBV levels (range
1763–112.000 copies/mL) were confirmed in the absence of a
complete seroconversion (no anti-EBNA production).
Supposing a primary immunodeficiency (PID), Sanger se-
quencing was started for known genes as causative of defects
in lymphocytes and infections (i.e., RAG, JAK3, CXCR4), but
no mutations were found. Considering the clinical hallmarks
of idiopathic CD4 lymphopenia, WES was started and among
113million reads and a mean coverage of 109X, variants were
annotated to (1) dbSNP database, (2) the in-house internal
database, and (3) the ESP6500 database. Only variants pre-
dicted as probably damaging or damaging (Polyphen2) in ei-
ther heterozygous or homozygous forms (gMAF <0.05 for
rare diseases, SIFT <0.5) were considered. No PID-causative
genes were identified by comparing the exome data with the
list of PID genes reported in Al-Herz et al. [S2] (Table S2).
Although no mutations were observed in KS-associated genes
[1–3], two heterozygous variants were found in the APOE and
FCGR3A genes. Although no further analyses were per-
formed on these variants to directly correlate these genes with
the clinical phenotype of KS, we cannot exclude a genetic
predisposition to develop KS in this clinical case.
We then moved to study large structural variants, and by
copy number variation (CNV) algorithm [S3], we detected a
large deletion in the MAGT1 gene (76 Kb deletion at hg19,
chrX:77,056,603–77,142,993, extending from exon 2 to the
proximity of the ATRX promoter; Fig. 1b). WGS with low
Fig. 1 Characterization of X-MEN patient. a Lymph node involvement
by Kaposi sarcoma: A diffuse proliferation of spindle cells forming slits
containing red blood cells (HE, 4×, inset 20×), B HHV-8 positivity in
nuclei of spindle cells (4×, inset 20×), and C CD34 positivity of spindle
cells (10×). b Schematic representation of primers’ design for the
identification of the deletion in MAGT1 gene. Deletion in the proband
and carrier was confirmed by genomic amplification/DNA sequencing.
Predicted structure is showed. c Pedigree of the family. The patient is
indicated by an arrow. d Quantitative RT-PCR showing expression of
MAGT1 mRNA in T cells normalized to telomerase. Results
represented as relative to HD. e Western blot on T cells from patient,
mother, and HD. MAGT1 30KDa. Actinβ 40 kDa. f Mg2+ basal levels
in the patient (red line) and HD (blue line). g Calcium flux in freshly
isolated PBMC from the patient and HD stimulated with anti-OKT3
(5 μg/mL) shown as percentage of responding cells as a function of
time. HD: healthy control
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coverage (∼10×) was then applied as confirmatory test in order
to identify the correct breakpoint sites. In-depth analysis of the
family indicated that the mother was the carrier of the mutation
(Fig. 1b, Tables S3–S4 for primers design), while other family
members were normal (Fig. 1c). We confirmed the mutation
also by quantitative real-time PCR on cDNA (Fig. 1d and
Figure S2). As expected, MAGT1 protein was expressed in
the mother and healthy donor (HD) (Fig. 1e). Consistently with
the diagnosis of X-MEN disease[S4], our patient has reduced
basal levels of free Mg2+ (Fig. 1f), which impaired proper sur-
face expression of NKG2D, which was also decreased at the
intracellular level and in CD8+ T cells (data not shown).
NK cell maturation is associated with the sequential acqui-
sition of specific receptors and functions. CD161, CD56, and
the activating receptor NKp44 are the first cell-surface markers
expressed during early NK cell development. Other receptors,
including NKG2D and CD16, are gradually acquired during
later stages of differentiation [S5]. The frequency of NK cells
in this patient was reduced for age, with slight impairment in
their cytotoxicity against K562. Although CD16+CD56dim
was detected, the expression of lineage-committed markers
CD161 and CD16 was decreased twofold as compared to con-
trols (Figure S1A–B and data not shown). To our knowledge,
this is the first description of an impairment in the early stage of
NK cells development in X-MEN patients.
Since abrogation ofMg2+ influx due toMAGT1 deficiency
has been reported to be associated with decreased Ca2+ influx
in T cells [S6], we studied Ca2+ influx in patient’s PBMC
stimulated with OKT3 (5 μg/ml) (Fig. 1g). We found a similar
increase in Ca2+ influx but the ratio of peak/background was
lower in the patient.
An in-depth time course analysis of TCR activation showed a
lower pick of phosphorylated PLCγ1 at 5 min after stimulation
with H2O2 (5 mM) in the patient and his mother with respect to
HD [S7-S8] (Figure S1C). Moreover, the ability to phosphory-
late PLCγ1 was reduced by four- and twofolds in the two sam-
ples as compared to the control, and the patient’s cells failed to
sustain TCR activation at more than 30 min. Our case report
supports the involvement ofMg2+ influx in the defective PLCγ1
phosphorylation, which controls Ca2+ influx after T cell activa-
tion, although we cannot exclude a direct effect of MAGT1
protein on the modulation of T lymphocyte calcium influx.
Susceptibility to severe EBV infection in patients with X-
linked lymphoproliferative disease is a classic model of a nar-
row infectious phenotype, caused by the requirement for a
specific co-stimulatory receptor–ligand interaction between
T cells and EBV-infected antigen-presenting B cells. The re-
duction of NKG2D in both NK+ and CD8+ cells debilitates
specific NKG2D ligand-mediated cytotoxic functions, which
play essential roles in anti-EBVand antitumor immunity.
This case describes for the first time the association of KS
with MAGT1 deficiency in a pediatric patient with clinical
presentation atypical from known pediatric and adult classic
KS. KS in childhood, whether isolated or associated with oth-
er infections, should be investigated for rare single-gene in-
born errors of immunity in the absence of HIV infection. In
addition to the improvement of antiviral immunity, control of
EBV infection and avoidance of lymphoma, free intracellular
Mg2+ may also play an essential role in the control of HHV8
infection. Our study provides evidence that the combination of
novel techniques (WES andWGS) in a single patient can lead
to the successful identification of the genetic basis of rare
monogenic immunodeficiency, expanding the clinical vari-
ability associated with MAGT1 mutations.
Compliance with Ethical Standards
Source of Funding The authors would like to thank the European
Commission-Advanced Cell-based Therapies for the treatment of
Primary Immunodeficiency (HEALTH-F5-2010-261387, CELL-PID to
AA andAF), the Italian TELETHON foundation (TIGETCore grant A1),
The Italian Ministero della Salute (Programma di rete, NET-2011-
02350069), Fondazione Roma and Italian Ministero della Salute (RF-
2009-1485896 conv.055), and Ospedale Pediatrico Bambino Gesù
Ricerca Corrente (201602PI003708) to CC and AF. IB is supported by
the Italian Ministero della Salute (GR-2011-02346985). This work was
supported in part by the Intramural Research Programs of the National
Institute of Allergy and Infectious Diseases, National Institutes of Health.
The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Conflict of Interests The authors declare that they have no competing
interests.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J,
et al. Inherited human OX40 deficiency underlying classic Kaposi
sarcoma of childhood. J Exp Med. 2013;210:1743–59.
2. Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A,
Telhan L, et al. Whole-exome sequencing-based discovery of
STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J
Exp Med. 2010;207:2307–12.
3. Jackson CC, Dickson MA, Sadjadi M, Gessain A, Abel L, Jouanguy
E, et al. Kaposi Sarcoma of childhood : inborn or acquired immuno-
deficiency to oncogenic HHV-8. 2016;392–7.
4. Li F-Y, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo
MJ. XMEN disease: a new primary immunodeficiency affecting
Mg2+ regulation of immunity against Epstein-Barr virus. Blood.
2014;123:2148–52.
5. Patiroglu T, Haluk Akar H, Gilmour K, Unal E, Akif Ozdemir M,
Bibi S, et al. A case of XMEN syndrome presented with severe auto-
immune disorders mimicking autoimmune lymphoproliferative dis-
ease. Clin Immunol. 2015;159:58–62.
J Clin Immunol (2017) 37:32–35 35
